Financhill
Back

Albireo Pharma Quote, Financials, Valuation and Earnings

Albireo Pharma Price Quote

$44.54
-0.16 (-0.36%)
(Updated: February 2, 2023 at 8:20 PM ET)

Albireo Pharma Key Stats

Buy
80
Albireo Pharma (ALBO) is a Buy

Day range:
$44.52 - $44.80
52-week range:
$16.02 - $44.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.16
P/B ratio:
9.24%

Volume:
160.2K
Avg. volume:
587.2K
1-year change:
50.1%
Market cap:
$924.5M
Revenue:
$40.6M
EPS:
$-6.72

How Much Does Albireo Pharma Make?

Is Albireo Pharma Growing As A Company?

  • What Is Albireo Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.68%
  • What Is Albireo Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Albireo Pharma Stock Price Performance

  • Did Albireo Pharma Stock Go Up Last Month?
    Albireo Pharma share price went up by 106.85% last month
  • Did ALBO's Share Price Rise Over The Last Year?
    ALBO share price rose by 50.1% over the past 1 year

What Is Albireo Pharma 52-Week High & Low?

Albireo Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Albireo Pharma?

  • How Much Debt Does Albireo Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Albireo Pharma Have?
    Cash and short term investments quarterly total is $222.5M
  • What Is Albireo Pharma’s Book Value Per Share?
    Book value per share is 4.84

Is Albireo Pharma Cash Flow Positive?

  • What Is ALBO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$115.3M
  • What Is Albireo Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $128M
  • What Is Albireo Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$960K

Albireo Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALBO return on invested capital is -86.35%
  • What Is Albireo Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -46.51%
  • What Is ALBO Return On Equity?
    ROE is a measure of profitability and is -91.17%

Albireo Pharma Earnings Date & Stock Price

Albireo Pharma Competitors

  • Who Are Albireo Pharma's Competitors?
    Below is a list of companies who compete with Albireo Pharma or are related in some way:
    • Calithera Biosciences Inc (CALA)
    • CinCor Pharma Inc (CINC)
    • Concert Pharmaceuticals Inc (CNCE)
    • Cutera Inc (CUTR)
    • Revance Therapeutics Inc (RVNC)

Albireo Pharma Dividend Yield

Data Unavailable

Albireo Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.03%
Revenue: 168.34% 3.07%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 47.00
Upside from Last Price: 5.15%

Major Shareholders

  • How many ALBO shares are owned by institutional investors?
    33.2M ALBO shares are owned by institutional investors
  • How many ALBO shares are owned by insiders?
    4.1M ALBO shares are owned by insiders